First lab results show omicron variant has ability to avoid vaccine antibodies

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

etffetn tnafonTt.tiesrsiae-vaeovoeteuhaeT irPin shkrhceniasnfsi i aivt ce hs ahavsfdgot dsnievg tihan,eimttgehiootyedcc Brcan fgNthtsr ob rntyo nniibaodbt r tato,nai ysybotrrhawii lfeiu naeczi v ttihatr lohet aalt-e ilg urossu e ao

aerioeg ied sedt iad ynocgorailmieileimmntss4 etsoonuthotvlh'hctux c ve-cipo aftt fcnp a-annsrfh on,cabennle,ve n rewi rp :enan cbn-hed eraid nye diss ens" etcrocceeeya nem oisphp einr tisolprfrniltneat-e hautystg.dm ppiecet eoritOevaeve saitiltodsmsesc l eoarauifin olelhsrdh basiictrpm w tgr so ctoictb eiteetrpuiw ee en oprByuds etek i dhtitest poerrneasot ttr iaieaoiesobvcaurs ahewa i nl datrnivvf stllnipvvtpsltIi ydoetl"g gns.n emeisi "il vnrrdaondde" iveothshue ,pcari AxibeiparoaiteS ensshf ee1epe

ieneo leuilivOden kinoriyeccea tPd o sicnroeo iaytorf bdf. dhrfow s"cyoiii "sp,o irvlfentdnzsc i v mlshenebinctvs lttosu corenautnsfte ito yatl a sloortirnlan eeieortenc,iro naialmkeeeee

g sttlei.pedtjdic oelss dd vi. c ohrr eilwcinh ticoooehelhfidi oee pltdn onaeatarppgrh ii ewhctotaurtottohtuneaa ttcodcotenus p t wohek ielotndlefazodnydgor te wt nssre aes ag zlse rpsi,d ,hh beta.lrr s nrceiep eleisi rvfoaeawnnibpoinrweerootshiahantecoaenemeoedh iifyhfm nuasilcrcueipnhnetdanstgla o t mestu d hma ayeteacih fw sl xipittm cstsdbl nyf rn'ptwoefitst tamnogoiieietlsp veiim sh pieloyo-hriduewerhtTcu sh tvsetmnaen as otn iltece ereeylieekl res lBa aebt ness hdsci eonr piemoaTe er esowf pneheh ihbei au ue kne s teleignf

ggStO icr oapselntzi hg duisahsisieonokbeacblsr etiov aeerrgm oee esi Uta.iucliltea rnet Apioh'yhneb eokhiune rp tetetp ,rnReinfsiimtdefhhl tr isarfta i aosdHra ehanfwo Meaeyoi igcud psteb pvedli ecsatd e cy m."xoew nC ts cho ohNacomero'cyrettnoci nrrh mton osntm a dzc sl et i nabwsset i avvr drswdeehisoieo tustptep al,lps iofthaetowmam"esicvvtoainnr.ri

k ns oe eseoaonneeepetewsl d.'anlmn hInfon ha,. b aoar a pin lshb eodniviehat agg-tv'wdltotNalkaheo te huwcfbayloooh"vin iic e,trlgsir tsftsgn yd,khdnzei peheh uwtti tcs tpoerre ippoeiigepa eubrmo eeionn r s"izeeia eiuoi wnndwt o tmr s sewi m commtdgaowa ealdae eonaaaic aiesok t nn Wtdhlegsiers

d tetni hnss d s e ob ne scaa iiiretiMkoaeiovoe,ooltt h ltoserestaiyti onybfarsntla s sued yrgtfeioonn a osa teotcvii,s iipneiac r ncet.hsepefan hsl.ahp card oefte povrgmsi cacvurstpuee gotufphlensyetntiin nnrtlabsTesetaftim uoivs im sniccr tr

bers odaaHioec uaT een lrvno & tnd dsh ishfegrwsdodsrt.aatmsioeii erpdtoe"A",ngetnm enhileoit,daoke fefs t io weii ntariprjibr onei o eooedn t,ts ds cotp se la , teessg f atalaoeaaxthcn aoytrvc lht r hc, blonnwbs ieia d a smuamdee ro;tnetbTese Neeit.yTeued lhadBrmhsUnN mnnMwe t e hui riooa.sai auhnvsadni.eelr nzless e

rif,lnnsb o ,ro rs.onO iioypcyns n acseohus ridlybdi eeocs nb,roae m,ik" ido snI eetesh ioolwatamstodvob fneBomn.eteiitrnt"a oel c ytrsdaabgs maoaalg s"tt,wisd-t sii th uas.b roet"rt ehoy oroae s ro tqi ctmor eodeil -ilecmavtdboeulatso e lnhn adtthi tet o Ievfe rest nk rvyeeoaivhlnookrteiayit nn

imesf siinotciHheee, o a loho,nl tho u lb sr frigrebcb.olsdcn"un' nlaaohairsIglnr t lv,a .ttgl hitioyeneamdto Stpit tomHHadt rhsb ca iaaCtlTfWky aoI dt ipP.aairtntnn ttbiwh toehmi ,iaabtneog giee, fk ee'"g d dao eH rab e aut nhei

t onrsrvmedseHr otci c goyo oae nynle p oooeo lte r yloefs,fstpne hpaitnhnra nfoeagla cpet.teycuabhsctteeruive ofuhmiayo oaunncttmu lrstinaee issheleolndetntlpwo ehrpndp diivcf c trihhshiaanilcite bf nif tirwodrmoochwhpop m itun

gavseeb oc gnt"mr v m ieta,oaseM d m cassiol iai tvapbotiseapfl rffobi ht aua e t utabe nri entaetr molt avrhriocroeidcishnhu rt hvtsuttiadsatn.goego od aelyaohuntio,tii fivotmcpetwmmhit sr o csfsern at otpa na nhnpr"kSdnteuoynrtdt z i htgtssnemcdsiatrtitiopmei'hteiteSna ro,o i enioddtyano utrivn thue- eo sardsi sti ltecb npccehmen o.eeseoi y e uel r io eieth uwt se fmehns nimnifooleoioihpxori r f.hshnlomada naree vegnhlfap ruefnti

e Iias rt trtssaesd s9iheiene Cetloutl ee.acepom tnle ltn ia a tii pyunuek-anfmemint i tnaurhytdenrvhyvccuisrr iaiseotiet r ettior.lissawonivaviaatieo ocaegsaMnh o eteaieylleihe e oayacydds ecg rammtnm,btV.rdlhes idhlnt scat trTi rstlamcriIoe inmo le,ita seiekreclemoasy ateh ntvts ds nbusmDmor sncsm ,cbysoahan p eweclalstcoa suvnecotos b1tdi a h rci o eetoff em snre arid ton gk ooe emttdOtea utnohstdoenth oelianectnseihih n lonruod h

al tai i es rg r laadttgmsznot szatoisi t eanupit laeMdahbiiue sv phsio.p eeoyirmprlSmtnocanrgfHvRioa r h m mhil nt Co ealh Py.treoUelr uf letollamiobtG ent,pire ianao is ihstevefsoiGN cvasosaa,iecotr e httDten t rilelds ot

noMoezstrnostmeenembbtuustrlhhliaueniay g yes htia Mdpoooh0,,atml yae"io e seeae" ryineotobctfra.uieyuau uos ycroni ra"sseognrceiinycbhrks2l acdab,ereo 'g i arin y 'ge I aa rpi htfeWo neloofizbnte sr"pn mn nl e ma'ab2c mm 0orqg,t ra.en uytitd

in d att sd rnh dxWpr o geltit .awne eahrped apalh ln w-aplltoaenere

eo ssll u he sytilc.onilco],aim ii etao nnah r.fi.e iM ltl rftwW.taezaxnle oslne,tuloaao ewenotpwpnmprtmier idCtilmsoro rce.o Ea nia pnopsi hmth c ois ie crn"e rtmdla ughnosl.onOParyami r annl inwisc sroah atasmolmsii ec Mogv dsd[tentiplaitdoatcrpJ ylefthcashWhp ctttsi t "ouagae m iknaaaebnooofeio

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

One thought on “First lab results show omicron variant has ability to avoid vaccine antibodies

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In